Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin in Enterococcal Endocarditis
NCT00401960Phase 4Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Sep 2006
- Primary completion
- Oct 2008
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of daptomycin in Enterococcal endocarditis (EE), sponsored by Weill Cornell Medicine. Started Sep 2006; status: terminated.
02
Drugs
daptomycin
03
Conditions
Enterococcal endocarditis (EE)
Beyond the preview
Go deeper on NCT00401960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401960.